SCHEMBL22373883

SCHEMBL22373883

Cc1cc2oc3ncccc3c2cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ HSP90AA1 P07900 2/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ CYP1A2 P05177 2/20 0.35
▸ CYP2A6 P11509 1/20 0.35
▸ HTT P42858 3/20 0.34
▸ CCR1 P32246 1/20 0.34
▸ CCR8 P51685 1/20 0.34
▸ SLC6A2 P23975 1/20 0.34
▸ PDE4D Q08499 2/20 0.34
▸ CYP1B1 Q16678 1/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ MAPT P10636 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ TDP1 Q9NUW8 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22373919 0.87 ALDH1A1 (0.46) KDM4EALDH1A1HSP90AA1NPC1L3MBTL1
SCHEMBL22373875 0.78 L3MBTL1 (0.41) KDM4EALDH1A1HSP90AA1NPC1L3MBTL1
SCHEMBL19725780 0.78 ALDH1A1 (0.47) KDM4EALDH1A1HSP90AA1NPC1L3MBTL1
SCHEMBL17033990 0.77 AHR (0.47) KDM4EALDH1A1NPC1CYP1A2CYP2A6
SCHEMBL24624526 0.75 KDM4E (0.51) KDM4EALDH1A1HSP90AA1NPC1L3MBTL1
SCHEMBL13509560 0.75 ALDH1A1 (0.51) KDM4EALDH1A1HSP90AA1NPC1L3MBTL1
SCHEMBL11884996 0.74 KDM4E (0.54) KDM4EALDH1A1HSP90AA1NPC1L3MBTL1
SCHEMBL11884983 0.73 KDM4E (0.55) KDM4EALDH1A1HSP90AA1NPC1L3MBTL1
SCHEMBL21026833 0.73 KDM4E (0.43) KDM4EALDH1A1NPC1CYP1A2CYP1B1
SCHEMBL14232864 0.72 CCR1 (0.42) KDM4EALDH1A1HSP90AA1NPC1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230389413-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2023-11-30 — — US disclosed
US-20230389413-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2023-11-30 — — US disclosed
US-11758807-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION 2023-09-12 — — US disclosed
US-11758807-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION 2023-09-12 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20200274081-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2020-08-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230389413-A1 Organic Electroluminescent Materials and Devices GLRA3, ESRRG, GLRA1 KDM4E 2665/4885ALDH1A1 2102/4885HSP90AA1 4213/4885
US-20200274081-A1 Organic Electroluminescent Materials and Devices GLRA3, ESRRG, GLRA1 KDM4E 2665/4885ALDH1A1 2102/4885HSP90AA1 4213/4885
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 KDM4E 3767/4885ALDH1A1 3072/4885HSP90AA1 4673/4885
US-11758807-B2 Organic electroluminescent materials and devices GLRA3, ESRRG, GLRA1 KDM4E 2665/4885ALDH1A1 2102/4885HSP90AA1 4213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback